Skip to main content
. 2021 Sep 14;11(9):1359. doi: 10.3390/biom11091359

Figure 3.

Figure 3

Frequency of diagnosed immunodeficiencies in 262 Austrian ME/CFS patients based on laboratory testing and clinical history. Blue bars indicate the percentage of clinically diagnosed immunodeficiencies in the ME/CFS patients’ cohort. Due to the descriptive evaluation of the data, no statistical comparison has been performed.